News
Opioids are currently the main cause of drug overdose deaths. In the United States in 2020, opioids were involved in 68,620 overdose deaths — 74.8% of all drug overdose deaths — according to ...
Attorney General Alan Wilson announced approximately $720 million nationwide in settlements with eight drug makers that ...
Hosted on MSN5mon
FDA approves first opioid-free painkiller in over two decades - MSNR ICHMOND, Va. (WRIC) — The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to severe acute pain in more than 20 years.
Advisers to the US Food and Drug Administration will meet Wednesday to discuss whether a nasal spray version of the opioid overdose antidote Narcan should be made available over-the-counter.
The Food and Drug Administration’s latest plan to study whether opioids are effective as a chronic pain treatment is facing significant resistance from addiction and pain care experts. A planned ...
Despite the ongoing opioid crisis plaguing the nation, the US Food and Drug Administration on Friday approved a new opioid medication five to 10 times more powerful than fentanyl. Dsuvia, made by ...
Of the 1.1 million Medicare recipients with opioid-use disorder, 170,408 were prescribed buprenorphine in 2021, of which just 1,245 – or 0.7% – potentially misused the drug due to high dosages ...
In a long anticipated decision, the Food and Drug Administration approved an over-the-counter version of naloxone spray, a generic form of the opioid overdose treatment called Narcan.
The Brief. The FDA approved Journavx, the first new pain medication in over 20 years, as a non-opioid alternative for post-surgery pain. The drug, developed by Vertex Pharmaceuticals, blocks pain ...
On Thursday, Jan. 30, The U.S. Food and Drug Administration announced that it has approved a new non-opioid painkiller pill from Vertex Pharmaceuticals called suzetrigine, which is being sold ...
The Food and Drug Administration on Friday approved the first version of over-the-counter (OTC) naloxone from a nonprofit company, a move that could bring cheap and even free doses of the opioid ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results